Recorded active ingredients: Lysine acetylsalicylate
Based on a snapshot of pillintrip.com listings. Country listings do not confirm current availability or registration. Sources and limitations · How matching works.
These listings match the full ingredient set recorded for Aspisol. Strength, dosage form and route may differ or be missing. This does not establish interchangeability; confirm a suitable product with a pharmacist.
Hypersensitivity, gastric ulcer and duodenal ulcer, increased bleeding, glucose−6-phosphate dehydrogenase deficiency, bronchial asthma.
Incompatible with anticoagulants. Enhances the effect of NSAIDs and sulfonylurea derivatives, methotrexate toxicity. Reduces the effect of furosemide, spironolactone, anti-inflammatory agents.
NSAIDS-gastropathy, gastrointestinal bleeding, thrombocytopenia, anemia, allergic reactions.
Pain syndrome (myalgia, arthralgia, neuralgia, after surgery), fever, rheumatic diseases, neuritis, thrombophlebitis of superficial veins, postoperative thrombosis and embolism.
Keep out of reach of children.
Shelf life of the drug Aspizol®3 года.Do not use after the expiry date which is stated on the packaging.
1 vial of dry substance for the preparation of the solution for injection contains 900 mg of D, l-lysine mono (acetylsalicylate), which corresponds to 500 mg of acetylsalicylic acid and 100 mg of aminoacetic acid.
1 ampoule with solvent contains 5 ml of water for injection, in a pack of 5 pcs.
Contraindicated.
In / and deep in / m-1-2 vial (per day no more than 10 g). The usual daily dose of acetylsalicylic acid for infants and children is 10-25 mg/kg of body weight, which corresponds to 0.1-0.25 ml of ready-made solution for injection. This daily dose should be divided into 2-3 single doses. The solution must be prepared again each time.
N02ba01 Acetylsalicylic Acid